BioSpace News Archive

Spero Therapeutics, Inc. (Nasdaq: SPRO) (Spero) today announced that Ankit Mahadevia, M.D., President and Chief Executive Officer of Spero Therapeutics, will participate in a fireside chat and be available for one-on-one meetings at the 5th Annual Evercore ISI HealthCONx Conference.

Cue Biopharma, Inc. announced that it will take part in two fireside chats, the first at the Piper Sandler 34th Annual Healthcare Conference, to be held November 29-December 1 in New York, and the second at the JMP Securities Hematology & Oncology Summit, to be held virtually December 6-7.

Icosavax, Inc. (Nasdaq: ICVX) today announced that the company will participate in and host one-on-one meetings at the 5th Annual Evercore ISI HealthCONx Conference taking place November 29 through December 1, 2022.

PaxMedica, Inc. (Nasdaq: PXMD) today announced it will be presenting at the Benchmark Company’s 11th Annual Discovery One-on-One Investor Conference to be held Thursday, December 1st, 2022 at the New York Athletic Club in New York City.

NextCure, Inc. today announced that it will present at the following investor conferences.

Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage biopharmaceutical company developing proprietary antibody-based therapeutics to treat cancer, today announced that the Company will participate in the Piper Sandler 34th Annual Healthcare Conference, which is taking place at the Lotte New York Palace November 29 – December 1, 2022.

Florida Cancer Specialists & Research Institute, LLC takes exception to a recent study published in the New England Journal of Medicine suggesting that colonoscopies are not as effective at preventing colorectal cancer deaths as previously thought.

Global molecular diagnostics innovator Sense Biodetection announced it has entered into a strategic agreement with R-Biopharm Nederland B.V. for the non-exclusive distribution in the Netherlands, Belgium, and Luxembourg of Sense’s Veros instrument-free, point-of-care molecular testing platform.

Insulet Corporation, the global leader in tubeless insulin pump technology with its Omnipod® brand of products, announced that management will present at two upcoming investor conferences: The Nasdaq 47th Investor Conference in London on Tuesday, December 6, 2022 at 6:30 a.m.

AccuStem Sciences, Inc., a clinical stage diagnostics company dedicated to improving outcomes for patients with cancer, announced that its Chairman of the Board, Mr. Gabriele Cerrone, has notified the Company that he has recently purchased an additional 24,500 ACUT shares in the open market.